Client Overview
The client is a biotechnology company based in the Netherlands seeking to submit a USDMF to the FDA. The engagement focused on preparing and reviewing the file to support a compliant US submission process.
Background
As the client progressed toward Regulatory engagement in the US, a well-prepared DMF became necessary to support product or material-related submissions. The client required expert support to organize, review, and finalize DMF content in line with FDA expectations.
Services in Scope
Preparation and review of USDMF documentation.
Regulatory support for USDMF submission to the FDA.
Compliance-oriented guidance for DMF content and structure.
Challenges
Need to compile and structure a submission-ready USDMF.
Requirement to align documentation with FDA’s DMF expectations.
Limited internal bandwidth or expertise to manage end-to-end DMF preparation and submission.
Solution
Freyr supported the client with a structured DMF preparation and review process to improve quality and submission readiness. The team aligned the file with FDA-oriented DMF expectations and helped the client progress toward a compliant submission.
1
Reviewed the available source content and identified requirements for a submission-ready USDMF.
2
Structured and prepared DMF sections in line with expected FDA formats and content needs.
3
Performed quality review to improve consistency and completeness before filing.
4
Supported the submission process for the finalized USDMF to the FDA.
Impact
- Strengthened the client’s readiness for a compliant USDMF submission.
- Improved document quality and submission structure for FDA engagement.
- Provided a clearer DMF pathway for future Regulatory interactions.
Concluding Remarks
Freyr assisted the client in structuring, reviewing, and submitting the USDMF, reducing uncertainty around FDA expectations and enhancing readiness. The framework supports future DMF updates and US regulatory activities.
